Percutaneous Breast Biopsy



Percutaneous Breast Biopsy





The capability of diagnosing a breast lesion percutaneously has dramatically improved the management of breast abnormalities over the last two decades. Prior to the development of these techniques, surgical excision was the procedure performed to identify the etiology of a nonpalpable mammographically detected lesion. The majority of these lesions, now classified as BIRADS 4—suspicious for malignancy—actually are benign. Until percutaneous breast biopsy was developed, many women underwent surgery for benign abnormalities to diagnose them.

Initially, fine needle aspiration biopsy (FNAB) was performed with mammographic (1) or sonographic guidance. The limitation of FNAB is the limited sampling and the need for an experienced cytopathologist for interpretation. Bolmgren (1) described the use of a stereotactic table that allowed for precise placement of a needle into a small lesion in the breast. Using this technology, percutaneous breast biopsy began its evolution. Core-needle biopsy techniques evolved as biopsy guns with Tru-cut-type automated needles of varying caliber were designed. Initially, 18-gauge core needles were used, followed by 16-gauge and subsequently 14-gauge automated core needles. The automated 14-gauge core needle is still used for the biopsy of masses, particularly with ultrasound guidance. Early results of core biopsy using a 14-gauge automated needle showed a sensitivity for malignancy of 85% (2) and a concordance between the pathologic results of core biopsy and surgery ranging from 87% to 96% (2,3,4,5). Parker et al. (3), in 1990, described biopsy utilizing stereotactic guidance in 103 patients, using a biopsy gun and automated cutting needles ranging from 18- to 14-gauge. The use of the 14-gauge needle improved the sample size and the results at pathology and, with this improvement, the management of breast abnormalities changed considerably.

Prior to the advent of the larger needles, a limited number of lesions were biopsied percutaneously—particularly cancers, complicated cysts, and fibroadenomas. However, many lesions, particularly fibrocystic lesions that were manifested as microcalcifications, yielded very nonspecific results on cytology and therefore were better diagnosed by surgical excision. With the development of percutaneous tissue sampling techniques, many more lesions could be biopsied by core biopsy instead of surgery.

The biopsy of microcalcifications has been challenging using core needles, because the volume of tissue removed is important to the accuracy of diagnosis for proliferative lesions. Vacuum-assisted breast biopsy probes have evolved to answer this problem, and larger samples can be obtained quickly and accurately using these devices. With the advent of vacuum-assisted biopsy, the speed of tissue acquisition, the volume of tissue acquired, and the accuracy for certain types of lesions have improved. Liberman et al. (6) showed that for calcifications that are highly suggestive of malignancy, the use of stereotactic 11-gauge vacuum-assisted biopsy was significantly more likely than the 14-gauge core needle or 14-gauge vacuum-assisted probe to spare a surgical procedure and was associated with the highest cost savings.

The advantages of percutaneous needle biopsy are many and include:



  • Improved cosmesis


  • Elimination of unnecessary surgery


  • Reduced cost


  • Improved efficiency in diagnosing a breast abnormality


  • Reduced patient morbidity


  • Less discomfort

Using percutaneous breast biopsy, benign lesions can be diagnosed accurately and do not require surgical excision in most cases.

Lesions that are suspicious for carcinoma can be proven to be cancer preoperatively. This is important in planning the proper surgery for the patient. Instead of performing a surgical excision for diagnosis, a lumpectomy with sentinel node biopsy can be performed with knowledge of the diagnosis. In particular, the diagnosis of invasive breast cancer on core biopsy allows for definitive therapy and increases the possibility of a single surgery. King et al. (7) reported that 90% of patients with invasive carcinoma on core biopsy could have a single surgery for definitive therapy. Liberman et al. (8) found that a single surgery was performed in 84% of women for whom the diagnosis of cancer was made on
core biopsy, in comparison with 29% of women in whom the diagnosis was made by surgical biopsy. Jackman et al. (9) found that a single surgery was performed in 90% of patients whose cancers were found on percutaneous biopsy, versus 24% of patients whose cancers were diagnosed surgically.

For multiple suspicious lesions, percutaneous biopsy is a very important tool to define the extent of disease. The presence of multiple cancers in one breast that involve more than one quadrant indicates multicentric disease (Fig. 16.1). This condition usually requires mastectomy for treatment. Therefore, the patient may be assessed by imaging and percutaneous biopsy, and be managed with definitive therapy—all without the need for unnecessary preliminary excisions. Rosenblatt et al. (10) found that multisite stereotactic biopsy had a positive effect on patient care in 80% of patients by helping to confirm the need for mastectomy or by documenting benign disease at multiple sites and avoiding unnecessary surgery.






Figure 16.1 HISTORY: 74-year-old woman with a palpable thickening in the left periareolar area, for second opinion after being told that she had multiple “cysts.”

MAMMOGRAPHY: Left MLO (A) and CC (B) views show multiple small masses in the left breast. The palpable thickening corresponded to a small indistinct mass at 4 o’clock, seen also on spot compression (C) (arrows). An indistinct mass is also noted in the upper inner quadrant (arrowheads), appearing spiculated on spot compression (D). Multiple other small round masses are present, primarily in the lower outer quadrant. Ultrasound demonstrated 10 small solid masses, including those seen on spot compression. Biopsy of five of these lesions was performed. Sonographic images of the palpable mass (E) and three other biopsied masses (F, G, H) are shown.

HISTOPATHOLOGY: Invasive ductal carcinoma, all sites. The patient underwent mastectomy for multicentric disease.

NOTE: Percutaneous biopsy is an ideal method to assess extent of disease in a patient with multicentric carcinoma.


Percutaneous biopsy is a less costly way of diagnosing a breast lesion than is surgery. Lee et al. (11) found an average cost savings of stereotactic biopsy versus open biopsy of $741 per case. The greatest savings occurred with indeterminate masses. Lindfors (12), in a study of the costeffectiveness of core biopsy found that the marginal cost per year of life saved by screening mammography was reduced a maximum of 23% (from $20,770 to $15,934) with the use of core biopsy instead of surgical biopsy. Liberman et al. (13) found that stereotactic biopsy decreased the cost of a breast lesion diagnosis by over 50%. Lind et al. (14) found that stereotactic core biopsy shortened the time from detection at mammography to diagnosis and breast-conserving therapy, permitted discussion with the patient of treatment options, reduced the positive margin rate and re-excision rate, and represented a cost savings in the management of nonpalpable breast cancer.


Ultrasound-Guided Biopsy

Ultrasound guidance is excellent for needle biopsy procedures in the breast. Cyst aspiration, fine-needle aspiration biopsy, and core biopsy can be performed readily for lesions that are visible sonographically. The benefits of ultrasound guidance include the ease of patient positioning, speed of the procedure, real-time visualization of the needle trajectory, low cost, lack of use of ionizing radiation, and the use of nondedicated equipment (15). Gordon et al. (16) found a sensitivity of 95% in 213 malignant lesions biopsied using ultrasound guidance and fine needle aspiration with a 20-gauge needle. Parker et al. (17) found that ultrasound-guided core biopsy using a free-hand technique with a long-throw 14-gauge core needle was a highly accurate alternative to open biopsy for the diagnosis of breast masses. Vacuum-assisted biopsy is
also performed with ultrasound guidance (18) and offers a rapid and accurate method to biopsy lesions.






Figure 16.2 Schematic for ultrasound-guided cyst aspiration shows that the needle is placed vertically, directly toward the mass. The needle tip is visible when it bisects the scan plane at the level of the lesion.






Figure 16.3 Schematic of a long-axis or horizontal approach that is used for core-needle biopsy with ultrasound guidance. The lesion is visualized in the center of the long axis of the transducer field, and the dermatotomy is made lateral to the edge of the transducer. This allows the needle to be placed horizontally, parallel to the chest wall, for a safer sampling when the needle is fired.

For cyst aspiration or fine-needle aspiration biopsy, a small-gauge hypodermic needle is used. The needle may be connected with thin, short tubing to a 20 cc syringe, allowing the interventionalist to handle the needle with more control. For cysts, a 1-inch long, 21- to 25-gauge needle is used. For fine-needle aspiration biopsy, the smaller the needle, the better the sample, so a 25-gauge hypodermic needle is optimal. A vertical approach, as described by Fornage (19), may be used for needle placement for cyst aspiration or FNAB (Fig. 16.2). In this manner, the needle is placed the shortest distance from and directly into the mass. For this placement, the needle is placed at the midline of the long face of the transducer, and the needle is visualized once it is at the depth of the lesion. If a long axis or horizontal approach is used, the needle is placed at the short end of the transducer and is visualized in its entirety as it is advanced toward the lesion. The horizontal approach usually requires a longer needle to reach the lesion (Fig. 16.3).

For core-needle biopsy or vacuum-aspirated biopsy, a horizontal/oblique approach must be used. Because of the forward firing of the needle, it is imperative that an approach parallel to the pectoralis major muscle be used for safety (Fig. 16.4). Many of the core needles typically used for ultrasound-guided biopsy advance into the breast about 2 cm on firing. An angled approach could easily allow the needle to penetrate the chest wall. For core biopsy, the area is cleansed with antiseptic solution, and a sterile technique is used. The device is visualized in the scan plan. It can be very helpful to have the assistant hold the transducer so that the interventionalist can use both hands to control the needle and skin and to hold the biopsy gun. Lidocaine 1% is injected for local anesthesia, and a small dermatotomy is made. The location of the dermatotomy depends on the depth of the lesion. The deeper the lesion, the farther from the edge of the transducer is the dermatotomy made. If the dermatotomy is too close to
the edge of the transducer, the needle insertion will not be parallel to the chest wall.






Figure 16.4 Ultrasound-guided core biopsy being performed with an automated core needle using a long-axis (horizontal) approach. The patient is turned to allow access to the lateral aspect of the breast and to allow room for the biopsy apparatus.






Figure 16.5 HISTORY: A 29-year-old with a new palpable right breast mass.

MAMMOGRAPHY: Sonography (A) demonstrates the lesion to be hypoechoic, slightly lobulated, and well-defined with no acoustic shadowing. All the features suggest that this is most likely a fibroadenoma. Vacuum-assisted biopsy was performed with ultrasound guidance. Pre-fire (B) and post-fire (C) sonographic images show that the needle has traversed the lesion. One pass was made.

HISTOPATHOLOGY: Fibroadenoma (concordant with imaging findings).

Once the needle has been placed proximal to the lesion (pre-fire position), the patient is prepared for the first sample by reminding her that she will hear a loud sound. The gun is fired and the needle traverses the lesion (post-fire position) (Fig. 16.5). Vacuum-assisted probes (VAB) may also be used for ultrasound-guided biopsy (Fig. 16.6). Using VAB, the needle may be inserted through the lesion rather than fired, and then multiple samples are acquired utilizing suction. A clip may be placed under ultrasound guidance and is particularly important for very small lesions that may no longer be clearly evident on ultrasound after the biopsy. Some of the vacuum-assisted probes are designed for clip insertion through the probe. Also, clips loaded into a stiff introducer-type needle are excellent for direct clip placement following needle biopsy.

Ultrasound guided biopsy is an ideal method for the percutaneous biopsy of women with implants. The implant wall can be visualized as the procedure is performed. In the
case of patients with implants, it is imperative that care be used in administering the local anesthesia and in the dermatotomy so that the implant is not punctured. The horizontal approach must be used for needle placement and tissue sampling. Automated core needles, rather than vacuum-assisted probes, are better suited for patients with very thin breast tissue over the implant (Fig. 16.7).


Stereotactic Biopsy

The advent of stereotaxis has greatly impacted the ease of accurate needle placement into small nonpalpable lesions and has allowed for a nonsurgical approach. Stereotactically guided needle biopsy can be performed for nodules as small as 3 mm. Stereotaxis can also be used for needle localizations and is particularly advantageous for the localization of a lesion seen clearly on only one view and superimposed over dense tissue on the orthogonal view. Stereotactic guidance with vacuum-assisted needles has become the standard or typical way of diagnosing suspicious microcalcifications.

Core biopsy can be performed with stereotactic, sonographic, or magnetic resonance imaging (MRI) guidance. Stereotactic biopsy units can be prone tables on which the breast is dependant through an aperture in the table, or upright units (20) that attach to the mammography equipment. When the patient is biopsied using an upright unit, she may sit up if the lesion is located in the superior aspect of the breast. However, if the lesion can be biopsied via a medial, lateral, or inferior approach, the patient lies on a stretcher in a decubitus position for the procedure (Fig. 16.8) (21,22).

The advantages of the upright unit are the ease in positioning the patient, the access to the posterior aspect of the breast, the comfort of the patient in not having to lie prone, the ability to use the room for general mammography as well as biopsy, and the interaction of the biopsy team with the patient. Advantages of the prone table unit are the access to the inferior aspect of the breast, the lack of patient visibility of the procedure, and the rarity of a vasovagal reaction.

The principle of stereotaxis is based on the movement of the x-ray tube relative to the breast at angles of a fixed degree of obliquity that allow for the precise calculation of the lesion location. The technique described here is based on the Siemen’s Opdima stereotactic unit (Siemens Medical Solutions, Malvern, PA), but various stereotactic units are designed around similar basic principles and procedures. The breast is compressed and is not moved during the entire procedure. Two 15-degree oblique spot views of the lesion are made (stereotactic pair). The radiologist identifies the lesion on each image and confirms the reference point on the images. The reference point is a fixed point in the image receptor plate that is visible on the images. Based on the position of the lesion target point versus the reference point, the X, Y, and Z coordinates of the lesion are calculated by the computer. The length of needle to be used must be chosen and entered into the computer.

At the stereotactic unit, the needle is then zeroed, thereby moving the needle guides into position at a ΔX = 0, ΔY = 0, and ΔZ = 0. This position indicates that the needle tip is over the lesion on the X and Y axes and that, when the gun is fired, the target point of the lesion will be at the level of the center of the needle’s trough on the Z axis.

Following local anesthesia and a dermatotomy. the needle is placed through the guides. Repeat spot oblique views (a stereotactic pair) are made to confirm accurate needle placement. The needle position must be carefully analyzed on these pre-fire images, and these should show the needle tip at the leading edge of the lesion on both images (Fig. 16.9). If the needle is off position on the X, Y. or Z axis, its position must be adjusted based on the pre-fire images. If the needle is repositioned to any degree, a repeat stereotactic pair should be obtained. Examples of X, Y, Z, and complex errors are show in Figures 16.10, Figures 16.11, Figures 16.12, 16.13, and methods to correct the errors are described.

Once the needle position is accurate, the sampling begins. With a vacuum-assisted probe or an automated core needle, the gun is fired. The needle is fired within the breast a distance specific for each particular needle and gun; most needles advance about 2 cm into the breast. Therefore, the thickness of the breast must be sufficient to accommodate this throw or stroke of the needle. Sampling begins by retrieving tissue cores at every 2 o’clock position with a vacuum-assisted probe. Typically two rotations are made, yielding 12 core samples. This circumferential sampling pattern is rapid and accurate.

If an automated core needle is used instead, the needle is oriented in position at ΔX, ΔY, and ΔZ at 0.0 mm. The gun is fired, and the first sample is retrieved by withdrawing the needle. The needle is replaced into the breast, and similar samples are obtained at ΔX at +2 or 3 mm, ΔX at -2 to 3 mm, ΔY at +2 to 3 mm, and ΔY at -2 to 3 mm (Fig. 16.14).

For the biopsy of calcifications, specimen radiography is performed to verify that the lesion has been correctly sampled (Fig. 16.15). This step is not necessary for noncalcified lesions. The vacuum probe is withdrawn 5 mm, and a clip is placed through the probe and deployed into the middle of the biopsy site. This change in the ΔZ of 5 mm is made because the clip tends to deploy forward at the end of the trough and will lie deep to the lesion once the compression is released. A final stereotactic pair is obtained to confirm that the clip has deployed, and the needle is withdrawn from the breast. Compression is applied to achieve hemostasis, the wound is cleansed, and Steri-Strips are applied to close the dermatotomy. An ice pack is placed over the breast for 20 to 30 minutes, and the wound is assessed for hemostasis before the patient is discharged.







Figure 16.6 HISTORY: A 52-year-old woman with a history of benign cyst aspirations, who presents with a palpable mass in the left breast for biopsy.

MAMMOGRAPHY: Left ML (A) and MLO spot (B) views show a round isodense mass with indistinct margins in the superior aspect of the breast. Pre-fire image from the ultrasound (C) showed the mass to be complex, with a thick rind. Core-needle biopsy with vacuum-assistance was performed. The pre-fire image (C) shows the needle tip (arrow) at the proximal edge of the lesion. The post-fire image (D) shows that the needle has traversed the middle of the lesion (arrow). With the first pass, the fluid component was aspirated along with the tissue sample.

The second pre-fire image (E) shows that the remaining mass is smaller and solid in appearance, and the needle tip is in position (arrow). The post-fire image (F) shows the horizontal position of the needle, parallel to the chest wall, and the needle tip through the mass. A clip was placed into the mass. Post-procedure ML (G) and CC (H) views show the clip within the residual mass.

HISTOPATHOLOGY: Poorly differentiated invasive ductal carcinoma with papillary features.

For aspiration procedures using stereotactic guidance, a coaxial system can be used to avoid multiple needle punctures. A 19- or 20-gauge outer cannula can be placed at the proximal edge of the lesion, and 22-gauge needles are passed through the cannula for aspiration.

Stereotactically guided fine-needle aspiration is of help for small well-defined masses that are new in comparison with prior examinations and that are not seen or are not definitely identified as cystic on ultrasound (Fig. 16.16). Fluid can be aspirated from these cysts under stereotactic guidance. Either pneumocystography or
follow-up mediolateral and craniocaudal views should be performed to confirm the disappearance of the nodule.


Fine-Needle Aspiration Biopsy

FNABs for palpable breast masses have been performed with success in lieu of open biopsy (23,24). For a questionably palpable lesion that cannot be satisfactorily aspirated by palpation only, or for a nonpalpable lesion, fine-needle aspiration can be performed under stereotactic or sonographic guidance. The following criteria are critical for fine-needle aspiration of nonpalpable lesions to be of value: (a) extremely accurate needle placement, (b) good techniques of aspiration and preparation of the smear, (c) experienced cytolopathologists
for interpretation of the sample, and (d) accurate and consistent results for cytologic determination of benign and malignant lesions (25). The experience of the person performing the aspiration is reflected in the percentage of aspirates that have sufficient material for analysis (23,26).






Figure 16.7 HISTORY: A 53-year-old woman with a history of breast implants who presents with an irregular mass identified on mammography in the right breast at 3 o’clock.

MAMMOGRAPHY: Right breast ultrasound (A) shows an irregular hypoechoic mass with angulated margins and some surrounding edema. The sonographic features are highly suggestive of malignancy. The breast parenchyma is very thin in this area. The pectoralis major muscle (arrow) is visualized, as well as the anterior edge of the subpectoral implant (arrowhead).

Core-needle biopsy using an automated 14-gauge needle was performed. It is imperative that the needle be placed carefully and horizontally, keeping the needle and its trajectory parallel to the pectoralis major muscle and the chest wall. Pre-fire image (B) shows a proper needle position (arrow) proximal to the mass. Post-fire position (C) shows that the mass has been transversed (arrow) by the needle. Three core samples were obtained.

HISTOPATHOLOGY: Invasive ductal carcinoma.

Regardless of the mode of FNAB guidance, a 22- to 25-gauge needle is placed into the lesion, suction is applied, and the needle is moved back and forth within the lesion. The suction is released, the needle is withdrawn, and the aspirate is ejected from the needle onto the slides and is smeared and fixed. Multiple passes will increase the yield of cells for cytologic analysis. When mammographic guidance with a fenestrated plate was used for FNAB of nonpalpable breast lesions, Helvie et al. (27) found that only 46% of the aspirates

of 215 lesions contained representative material. If an aspirate of a suspicious mammographic lesion is negative, core biopsy or open biopsy is necessary for accurate diagnosis.






Figure 16.8 Patient is in position for stereotactic breast biopsy using an upright unit and a vacuum-assisted probe (Mammotome, Ethicon Endo-Surgery, Cincinnati OH). When the lesion is located in the upper aspect of the breast, a superior approach is used. For a lateral, medial, or inferior approach, the patient is placed in a decubitus position.






Figure 16.9 A, B: Accurate pre-fire needle position. The needle tip is at the leading edge of the lesion on both stereotactic images. The images must be analyzed together to understand where the needle tip is relative to the target point and where the needle tip will likely be once the gun is fired. The orientation of the X, Y, and Z axes are shown. C, D: Accurate post-fire needle position: After the gun has been fired, the needle has moved forward through the lesion, and the needle tip is traversing the target point on both images.






Figure 16.10 A, B: Y-axis error: The needle tip is above the target point on both images. If it is fired in this position, the lesion will be missed. This is the typical Y-axis error on the upright unit, because the patient has pulled back a bit and the lesion has moved back. The targeted point, therefore, lies anterior to the lesion on the stereotactic images. To correct this error, the ΔY is moved back (on the upright unit) or down (on the prone table). C, D: Y-axis error: The needle tip is below the target point on both views. This is the typical Y-axis error on the prone table, because the patient has pulled up a bit, moving the lesion above the needle tip. To correct this problem, the ΔY is moved up (on the prone table) or forward (on the upright unit).

Fine needle association biopsy under stereotactic guidance has been an option for the evaluation of nonpalpable solid lesions (28,29,30,31,32,33,34,35,36,37,38). Variable results from studies comparing cytology and histology for nonpalpable lesions have demonstrated a relatively high sensitivity and specificity for this procedure. For FNAB to be of value and to be cost effective, it is necessary that lesions called “malignant” be malignant and that no false positives occur. Otherwise, histologic confirmation would be necessary prior to definitive treatment. Because of the small size of these lesions, the mixed nature of the aspirate (38

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 26, 2016 | Posted by in ONCOLOGY | Comments Off on Percutaneous Breast Biopsy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access